Clinical and anamnestic risk factors for preeclampsia in pregnant women


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To build a prognostic mathematical model to calculate an individual risk for preeclampsia (PE) on the basis of clinical and anamnestic data. Subjects and methods. A retrospective case-control study covering 320 women was conducted. A study group consisted of 160 patients with PE. A control group was formed using the pair matching method in accordance with 2 signs: domicile (urban/area area) and social status (income level), which also comprised 160 women. The investigators analyzed the anamnestic risk factors of PE as a whole and also early PE (occurring before 34 weeks of pregnancy) and late PE (occurring at 34 weeks’ gestation) separately. Multivariate analysis (logistic regression) was used to construct a PE prognostic model and to calculate an individual risk. Results. The risk factors of PE are patient age and chronic hypertension. In this case, the only proven predictor for early PE is chronic hypertension (by 3.7 times more frequently) and that for late PE was a female age more than 36 years (by 2 times more commonly). A model to measure the individual risk of PE was built on the basis of clinical and anamnestic data. Conclusion. Different risk factors for various forms of PE may be suggestive of the different genesis of these conditions. Early PE is characterized by early vascular bed lesion, which proves the great risk of its occurrence in patients with vascular disease (hypertension). Late PE may show secondary impairment in placental blood flow at a late gestational age. The possible trigger of late PE is immunological intolerance, causing a systemic inflammatory response. The compromised somatic and obstetric risk associated with old patient age can make a tangible contribution to the development of these pathological processes.

Full Text

Restricted Access

About the authors

Natalia E. Kan

Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: kan-med@mail.ru
MD, PhD; the head of the Obstetrical observational department

Lev A. Bednyagin

M.Yu. Lomonosov Moscow State University

Email: levbed@mail.ru
student of the department of Fundamental Medicine

Nataliya V. Dolgushina

Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: n_dolgushina@oparina4.ru
M.D., Ph.D., M.P.H., Head of R&D Department

Victor L. Tyutyunnik

Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: tioutiounnik@mail.ru
PhD, MD, the head of the obstetric physiological department

Petimat A. Khovkhaeva

Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: p_hovhaeva@oparina4.ru
the postgraduate student

Olga A. Sergunina

Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: o_sergunina@oparina4.ru
obstetrician-gynecologist of the obstetric observation department

Nataliya V. Tyutyunnik

Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: tysia07@bk.ru
the resident

Elrad Y. Amiraslanov

Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: e_amiraslanov@oparina4.ru
scientific researcher, collaborator of the obstetric observation department

References

  1. Redman C.W.G., SargentI.L. Placental stress and pre-eclampsia: a revised view. Placenta. 2009; 30(Suppl.A): S38-42.
  2. Cronqvist T., Salje K., Familari M., Guller S., Schneider H., Gardiner C. et al. Syncytiotrophoblast vesicles show altered micro-RNA and haemoglobin content after ex-vivo perfusion of placentas with haemoglobin to mimic preeclampsia. PLoS One. 2014; 9(2): e90020.
  3. Hansson S.R., Nääv Å., Erlandsson L. Oxidative stress in preeclampsia and the role of free fetal hemoglobin. Front. Physiol. 2015; 5: 516.
  4. Roberts J.M., Hubei C.A. The two stage model of preeclampsia: variations on the theme. Placenta. 2009; 30(Suppl.A): S32-7.
  5. Myatt L., Roberts J.M. Preeclampsia: syndrome or disease? Curr. Hypertens. Rep. 2015; 17(11): 83.
  6. Von Dadelszen P., Magee L.A., Roberts J.M. Subclassification of preeclampsia. Hypertens. Pregnancy. 2003; 22(2): 143-8.
  7. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008; 51(4): 970-5.
  8. Irgens H.U., Reisaeter L., Irgens L.M., Lie R.T. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ. 2001; 323(7323): 1213-7.
  9. Mongraw-Chaffin M.L., Cirillo P.M., Cohn B.A. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension. 2010; 56(1): 166-71.
  10. Nelson D.B., Ziadie M.S., McIntire D.D., Rogers B.B., Leveno K.J. Placental pathology suggesting that preeclampsia is more than one disease. Am. J. Obstet Gynecol. 2014; 210(1): 66. e1-7.
  11. Stark M.W., Clark L., Craver R.D. Histologic differences in placentas of preeclamptic/eclamptic gestations by birthweight, placental weight, and time of onset. Pediatr. Dev. Pathol. 2014; 17(3): 181-9.
  12. Российское общество акушеров-гинекологов. Федеральные клинические рекомендации. Гипертензивные расстройства во время беременности, в родах и послеродовом периоде. Преэклампсия. Эклампсия. М.: ФГБУ «Научный Центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Министерства здравоохранения Российской Федерации; 2013. 85с. [Russian Society of Obstetricians anf Gynecologists. Federal Clinical Recommendations „Hypertension in pregnancy, labour or during postlabour period. Preeclamsia. Eclampsia.” 2013. 85p. Moscow: Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia; (in Russian)]
  13. The American College of Obstetricians Gynecologists. Guidelines: Hypertension in pregnancy. ACOG; 2012. 100p.
  14. Lisonkova S., Joseph K.S. Incidence of preeclampsia: risk factors and outcomes associated with early-versus late-onset disease. Am. J. Obstet. Gynecol. 2013; 209(6): 544. e1-544. e12.
  15. Hoirisch-Clapauch S., Benchimol-Barbosa P.R. Markers of insulin resistance and sedentary lifestyle are predictors of preeclampsia in women with adverse obstetric results. Braz. J. Med. Biol. Res. 2011; 44(12): 1285-90.
  16. Goetzinger K.R., Tuuli M.G., Cahill A.G., Macones G.A., Odibo A.O. Development and validation of a risk factor scoring system for firsttrimester prediction of preeclampsia. Am. J. Perinatol. 2014; 31(12): 1049-56.
  17. Myatt L., Clifton R.G., Roberts J.M., Catherine Y., Hauth J.C. et al. Firsttrimester prediction of preeclampsia in low-risk nulliparous women. Obstet. Gynecol. 2013; 119(6): 1234-42.
  18. Wright D., Syngelaki A., Akolekar R., Poon L.C., Nicolaides K.H., O’Gorman N. et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation. Am. J. Obstet. Gynecol. 2015; 213(1): 62. e1-10.
  19. Yliniemi A., Makikallio K., Korpimaki T., Kouru H., Marttala J., Ryynanen M. Combination of PAPPA, fhCGbeta, AFP, PlGF, sTNFR1, and maternal characteristics in prediction of early-onset preeclampsia. Clin. Med. Insights Reprod. Health. 2015; 9: 13-20.
  20. The American College of Obstetricians Gynecologists. Committee Opinion No. 638: First-trimester risk assessment for early-onset preeclampsia. Obstet. Gynecol. 2015; 126(3): e25-7.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies